tiprankstipranks
Innovent Biologics (HK:1801)
:1801
1801
Innovent Biologics
RESEARCH TOOLSreports
Want to see HK:1801 full AI Analyst Report?

Innovent Biologics (1801) Revenue

26 Followers
StatisticsMarket CapRevenue

Innovent Biologics Revenue

Innovent Biologics had a revenue of 6.97B in the quarter ending Dec 31, 2025, with 17.08%. This bring the company's revenue in the last twelve months to 12.92B, Decreased 13.14%. In the fiscal year ending Dec 31, 2025, Innovent Biologics had annual revenue of 12.70B with 34.83% growth.
Revenue (ttm)
12.92B
Revenue Growth
38.55%
P/S Ratio
12.63
Revenue/Employee
HK$2,244,919
Employees
5,659
Market Cap
HK$160.42B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
12.70B3.28B+34.83%
Dec 31, 2024
9.42B3.22B+51.82%
Dec 31, 2023
6.21B1.65B+36.21%
Dec 31, 2022
4.56B286.65M+6.71%
Dec 31, 2021
4.27B425.91M+11.08%
Dec 31, 2020
3.84B2.80B+266.94%
Dec 31, 2019
1.05B1.04B+10,953.34%
Dec 31, 2018
9.48M-9.06M-48.88%
Dec 31, 2017
18.54M――